BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9934476)

  • 1. Facile synthesis of high affinity styrylpyridine systems as inherently fluorescent ligands for the estrogen receptor.
    Meyers MJ; Carlson KE; Katzenellenbogen JA
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3589-94. PubMed ID: 9934476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of 4-styrylpyridines: synthesis, estrogen receptor binding affinity, and photophysical properties.
    Haroutounian SA; Scribner AW; Katzenellenbogen JA
    Steroids; 1995 Sep; 60(9):636-45. PubMed ID: 8545854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2-Diaryl-3,4-dihydronaphthalenes: photofluorogenic ligands for the estrogen receptor.
    Bindal RD; Katzenellenbogen JA
    J Steroid Biochem; 1985 Dec; 23(6A):929-37. PubMed ID: 4094420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsionally and hydrophobically modified 2,3-diarylindenes as estrogen receptor ligands.
    Anstead GM; Peterson CS; Pinney KG; Wilson SR; Katzenellenbogen JA
    J Med Chem; 1990 Oct; 33(10):2726-34. PubMed ID: 2213825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Pyridin-2-yl-1H-indole derivatives: synthesis, estrogen receptor binding affinity, and photophysical properties.
    Kasiotis KM; Haroutounian SA
    Bioorg Chem; 2006 Feb; 34(1):1-14. PubMed ID: 16325224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, receptor binding, and fluorescence properties of hexestrol-fluorophore conjugates: evaluation of site of attachment, fluorophore structure, and fluorophore-ligand spacing.
    Fevig TL; Lloyd JE; Zablocki JA; Katzenellenbogen JA
    J Med Chem; 1987 Jan; 30(1):156-65. PubMed ID: 3027331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of receptor.
    Hwang KJ; Carlson KE; Anstead GM; Katzenellenbogen JA
    Biochemistry; 1992 Nov; 31(46):11536-45. PubMed ID: 1445887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor.
    Henke BR; Drewry DH; Jones SA; Stewart EL; Weaver SL; Wiethe RW
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1939-42. PubMed ID: 11459665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-[omega-[4-arylpiperazin-1-yl]alkoxy]phenyl)imidazo[1,2-a]pyridine derivatives: fluorescent high-affinity dopamine D3 receptor ligands as potential probes for receptor visualization.
    Leopoldo M; Lacivita E; Passafiume E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Oct; 50(20):5043-7. PubMed ID: 17850060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of fluorescent steroidal ligands for the estrogen receptor 1995-2018.
    Gajadeera N; Hanson RN
    Steroids; 2019 Apr; 144():30-46. PubMed ID: 30738074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a novel fluorescent probe for estrogen receptor.
    Adamczyk M; Reddy RE; Yu Z
    Bioorg Med Chem Lett; 2002 May; 12(9):1283-5. PubMed ID: 11965371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-coordinate ligand for physiological beryllium imaging by fluorescence.
    Diyabalanage HV; Ganguly K; Ehler DS; Collis GE; Scott BL; Chaudhary A; Burrell AK; McCleskey TM
    Angew Chem Int Ed Engl; 2008; 47(38):7332-4. PubMed ID: 18683838
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding properties of coumestrol to expressed human estrogen receptor.
    Scarlata S; Miksicek R
    Mol Cell Endocrinol; 1995 Nov; 115(1):65-72. PubMed ID: 8674866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triarylethylene bisphenols with a novel cycle are ligands for the estrogen receptor.
    Kim SH; Katzenellenbogen JA
    Bioorg Med Chem; 2000 Apr; 8(4):785-93. PubMed ID: 10819167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approach for visualizing estrogen receptors in target cells using inherently fluorescent ligands and image intensification.
    Martin PM; Magdelenat HP; Benyahia B; Rigaud O; Katzenellenbogen JA
    Cancer Res; 1983 Oct; 43(10):4956-65. PubMed ID: 6883346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of benzodiazepine receptors with fluorescent ligands.
    McCabe RT; de Costa BR; Miller RL; Havunjian RH; Rice KC; Skolnick P
    FASEB J; 1990 Aug; 4(11):2934-40. PubMed ID: 2165950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent probes for dopamine receptors: synthesis and characterization of fluorescein and 7-nitrobenz-2-oxa-1,3-diazol-4-yl conjugates of D-1 and D-2 receptor ligands.
    Bakthavachalam V; Baindur N; Madras BK; Neumeyer JL
    J Med Chem; 1991 Nov; 34(11):3235-41. PubMed ID: 1956042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing of 2,3-diarylindenes as fluorescent estrogens: variation of the acceptor group, ortho substitution of the 2-ring, and C-1 methylation.
    Anstead GM; Katzenellenbogen JA
    J Med Chem; 1988 Sep; 31(9):1754-61. PubMed ID: 3411601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical concepts of on-line liquid chromatographic-biochemical detection systems. I. Detection systems based on labelled ligands.
    Oosterkamp AJ; Irth H; Villaverde Herraiz MT; Tjaden UR; van der Greef J
    J Chromatogr A; 1997 Nov; 787(1-2):27-35. PubMed ID: 9408993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxylated 2,3-diarylindenes: synthesis, estrogen receptor binding affinity, and binding orientation considerations.
    Anstead GM; Peterson CS; Katzenellenbogen JA
    J Steroid Biochem; 1989 Nov; 33(5):877-87. PubMed ID: 2601332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.